Growth Metrics

Haemonetics (HAE) Receivables - Other (2017 - 2022)

Haemonetics has reported Receivables - Other over the past 7 years, most recently at $6.6 million for Q4 2022.

  • For Q4 2022, Receivables - Other rose 20.0% year-over-year to $6.6 million; the TTM value through Dec 2022 reached $6.6 million, up 20.0%, while the annual FY2022 figure was $5.5 million, 14.58% up from the prior year.
  • Receivables - Other for Q4 2022 was $6.6 million at Haemonetics, down from $7.6 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $10.5 million in Q4 2018 and troughed at $4.0 million in Q2 2018.
  • A 5-year average of $6.1 million and a median of $5.6 million in 2019 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: surged 147.62% in 2018 and later crashed 34.33% in 2021.
  • Year by year, Receivables - Other stood at $10.5 million in 2018, then dropped by 23.81% to $8.0 million in 2019, then crashed by 32.5% to $5.4 million in 2020, then fell by 18.52% to $4.4 million in 2021, then skyrocketed by 50.0% to $6.6 million in 2022.
  • Business Quant data shows Receivables - Other for HAE at $6.6 million in Q4 2022, $7.6 million in Q4 2022, and $6.4 million in Q3 2022.